Cultivation of the marine cyanobacterium Moorea producens, collected from the Nabq Mangroves in the Gulf of Aqaba (Red Sea), led to the isolation of new apratoxin analogues apratoxin H (1) and apratoxin A sulfoxide (2), together with the known apratoxins A-C, lyngbyabellin B, and hectochlorin. The absolute configuration of these new potent cytotoxins was determined by chemical degradation, MS, NMR, and CD spectroscopy. Apratoxin H (1) contains pipecolic acid in place of the proline residue present in apratoxin A, expanding the known suite of naturally occurring analogues that display amino acid substitutions within the final module of the apratoxin biosynthetic pathway. The oxidation site of apratoxin A sulfoxide (2) was deduced from MS fragmentation patterns and IR data, and 2 could not be generated experimentally by oxidation of apratoxin A. The cytotoxicity of 1 and 2 to human NCI-H460 lung cancer cells (IC₅₀ = 3.4 and 89.9 nM, respectively) provides further insight into the structure-activity relationships in the apratoxin series. Phylogenetic analysis of the apratoxin-producing cyanobacterial strains belonging to the genus Moorea, coupled with the recently annotated apratoxin biosynthetic pathway, supports the notion that apratoxin production and structural diversity may be specific to their geographical niche.
Cultivation of the marine cyanobacteriumn class="Species">Moorea producens, collected from the Nabq Mangroves in the Gulf of Aqaba (Red Sea), led to the isolation of new apratoxin analogues apratoxin H (1) and apratoxin A sulfoxide (2), together with the known apratoxins A-C, lyngbyabellin B, and hectochlorin. The absolute configuration of these new potent cytotoxins was determined by chemical degradation, MS, NMR, and CD spectroscopy. Apratoxin H (1) contains pipecolic acid in place of the proline residue present in apratoxin A, expanding the known suite of naturally occurring analogues that display amino acid substitutions within the final module of the apratoxinbiosynthetic pathway. The oxidation site of apratoxin A sulfoxide (2) was deduced from MS fragmentation patterns and IR data, and 2 could not be generated experimentally by oxidation of apratoxin A. The cytotoxicity of 1 and 2 to humanNCI-H460 lung cancer cells (IC₅₀ = 3.4 and 89.9 nM, respectively) provides further insight into the structure-activity relationships in the apratoxin series. Phylogenetic analysis of the apratoxin-producing cyanobacterial strains belonging to the genus Moorea, coupled with the recently annotated apratoxinbiosynthetic pathway, supports the notion that apratoxinproduction and structural diversity may be specific to their geographical niche.
Authors: A Norrie Pearce; Elizabeth W Chia; Michael V Berridge; George R Clark; Jacquie L Harper; Lesley Larsen; Elizabeth W Maas; Michael J Page; Nigel B Perry; Victoria L Webb; Brent R Copp Journal: J Nat Prod Date: 2007-05-11 Impact factor: 4.050
Authors: Kevin E Ashelford; Nadia A Chuzhanova; John C Fry; Antonia J Jones; Andrew J Weightman Journal: Appl Environ Microbiol Date: 2006-09 Impact factor: 4.792
Authors: Kevin E Ashelford; Nadia A Chuzhanova; John C Fry; Antonia J Jones; Andrew J Weightman Journal: Appl Environ Microbiol Date: 2005-12 Impact factor: 4.792
Authors: Rashel V Grindberg; Thomas Ishoey; Dumitru Brinza; Eduardo Esquenazi; R Cameron Coates; Wei-ting Liu; Lena Gerwick; Pieter C Dorrestein; Pavel Pevzner; Roger Lasken; William H Gerwick Journal: PLoS One Date: 2011-04-12 Impact factor: 3.240
Authors: David A Gallegos; Josep Saurí; Ryan D Cohen; Xuemei Wan; Patrick Videau; Alec O Vallota-Eastman; Lamiaa A Shaala; Diaa T A Youssef; R Thomas Williamson; Gary E Martin; Benjamin Philmus; Aleksandra E Sikora; Jane E Ishmael; Kerry L McPhail Journal: J Nat Prod Date: 2018-05-29 Impact factor: 4.050
Authors: Daphne R Mattos; Marcus A Weinman; Xuemei Wan; Cheri P Goodall; Jeffrey D Serrill; Kerry L McPhail; Milan Milovancev; Shay Bracha; Jane E Ishmael Journal: Cell Stress Chaperones Date: 2022-03-04 Impact factor: 3.827
Authors: Weijing Cai; Ranjala Ratnayake; Michael H Gerber; Qi-Yin Chen; Yichao Yu; Hartmut Derendorf; Jose G Trevino; Hendrik Luesch Journal: Invest New Drugs Date: 2018-08-03 Impact factor: 3.850
Authors: Jeffrey D Serrill; Xuemei Wan; Andrew M Hau; Hyo Sang Jang; Daniel J Coleman; Arup K Indra; Adam W G Alani; Kerry L McPhail; Jane E Ishmael Journal: Invest New Drugs Date: 2015-11-12 Impact factor: 3.850
Authors: Thomas P Wyche; Jeff S Piotrowski; Yanpeng Hou; Doug Braun; Raamesh Deshpande; Sean McIlwain; Irene M Ong; Chad L Myers; Ilia A Guzei; William M Westler; David R Andes; Tim S Bugni Journal: Angew Chem Int Ed Engl Date: 2014-09-04 Impact factor: 15.336
Authors: Soheila Kazemi; Shinsaku Kawaguchi; Christian E Badr; Daphne R Mattos; Ana Ruiz-Saenz; Jeffrey D Serrill; Mark M Moasser; Brian P Dolan; Ville O Paavilainen; Shinya Oishi; Kerry L McPhail; Jane E Ishmael Journal: Biochem Pharmacol Date: 2020-11-03 Impact factor: 5.858